However, after PSG treatment, the expressions of ZO1 and occludin were significantly increased, while those of iNOS and COX2 were decreased (Figures 4(c) and 4(d)), showing the good efficacy of PSG in protecting the intestinal barrier from the damage of IBD mice. The gene discussed is TJP1; the disease is inflammatory bowel disease.